Predicts early spread of cervical cancer after radiotherapy
Studies a risk model to find cervical cancer patients who may spread early after radiation.
Plain-language title generated from the registry record
Registry title: A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Key facts
- Where
- Fuzhou, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with cervical cancer confirmed by biopsy who were treated with radiotherapy. It aims to predict early spread of the cancer.
- Age
- 20 Years to 85 Years
- Sex
- Women only
- Disease stage
- Cervical cancer confirmed by biopsy.
- Earlier treatment
- Must have been treated with radiotherapy. People treated with surgery, with incomplete treatment elsewhere, or with unfinished radical radiotherapy cannot join.
Main reasons for not taking part
- Treated with surgery
- History of another cancer
- History of pelvic surgery
- Cancer spread within 3 months after radiotherapy
- Missing pre-treatment medical information or 1-year follow-up data
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 85 years old?
Source: NCT06101966, who can take part
Where in China
- Fujian Cancer HospitalFuzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fujian Cancer Hospital
- Trial code
- NCT06101966
- Record updated
- 26 October 2023
- Original description
This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.Read full original descriptionShow less
A Novel Predictive Model and Risk Stratification for Early Metastasis in Cervical Cancer Patients After Radiotherapy
This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.
Inclusion: patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled.
Exclusion: (1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials.